The Canadian market has seen a promising start to the fourth-quarter earnings season, with the TSX showing solid growth and broad-based earnings improvements expected across multiple sectors. Amid this backdrop, penny stocks—though an outdated term—remain a niche area of interest for investors seeking potential growth in smaller or newer companies. These stocks can offer surprising value when backed by strong financial health, and we will explore three such examples that combine balance sheet strength with potential for long-term gains.
Top 10 Penny Stocks In Canada
| Name |
Share Price |
Market Cap |
Financial Health Rating |
| Westbridge Renewable Energy (TSXV:WEB) |
CA$1.985 |
CA$50.18M |
★★★★★★ |
| Cannara Biotech (TSXV:LOVE) |
CA$1.75 |
CA$167.62M |
★★★★★★ |
| Zoomd Technologies (TSXV:ZOMD) |
CA$1.18 |
CA$118.94M |
★★★★★★ |
| Montero Mining and Exploration (TSXV:MON) |
CA$0.70 |
CA$5.85M |
★★★★★★ |
| Medexus Pharmaceuticals (TSX:MDP) |
CA$2.83 |
CA$91.87M |
★★★★☆☆ |
| CEMATRIX (TSX:CEMX) |
CA$0.355 |
CA$53.15M |
★★★★★★ |
| Thor Explorations (TSXV:THX) |
CA$1.56 |
CA$1.04B |
★★★★★★ |
| Pulse Seismic (TSX:PSD) |
CA$3.83 |
CA$194.24M |
★★★★★★ |
| Caldwell Partners International (TSX:CWL) |
CA$0.97 |
CA$28.55M |
★★★★★★ |
| Hemisphere Energy (TSXV:HME) |
CA$2.07 |
CA$195.24M |
★★★★★★ |
Click here to see the full list of 370 stocks from our TSX Penny Stocks screener.
Let's uncover some gems from our specialized screener.
EcoSynthetix
Simply Wall St Financial Health Rating:★★★★★★
Overview:EcoSynthetix Inc., with a market cap of CA$230.75 million, is a renewable chemicals company that develops and commercializes bio-based technologies to replace synthetic, petrochemical-based chemicals across various regions including the Americas, Europe, the Middle East, Africa, and Asia Pacific.
Operations:The company generates revenue from its Biopolymer Nanosphere Technology Platform, amounting to $20.31 million.
Market Cap:CA$230.75M
EcoSynthetix Inc., with a market cap of CA$230.75 million, has demonstrated resilience despite being unprofitable. Its short-term assets of $37.3M comfortably cover both short and long-term liabilities, reflecting financial stability without debt for the past five years. The company reported sales growth to US$5.83 million in Q3 2025 compared to the previous year, although it remains unprofitable with a net loss of US$0.091 million for the quarter. EcoSynthetix has maintained its cash runway for over three years and recently completed a share buyback program worth CA$0.36 million, indicating confidence in its future prospects amidst market volatility.
TRX Gold
Simply Wall St Financial Health Rating:★★★★★★
Overview:TRX Gold Corporation focuses on the exploration, development, and production of mineral properties in Tanzania, with a market cap of CA$628.57 million.
Operations:The company generates revenue from its mineral exploration and development activities, amounting to $70.20 million.
Market Cap:CA$628.57M
TRX Gold Corporation, with a market cap of CA$628.57 million, is navigating the volatile landscape of penny stocks through strategic growth initiatives in Tanzania. Despite being unprofitable, TRX has reduced its debt-to-equity ratio significantly over five years and maintains a healthy cash runway exceeding three years due to positive free cash flow. The company reported substantial revenue growth to US$25.12 million for Q1 2026 and aims to increase gold production at Buckreef Gold by accessing higher-grade ore blocks. However, recent insider selling and increased share price volatility highlight potential risks for investors considering this stock.
Zoomd Technologies
Simply Wall St Financial Health Rating:★★★★★★
Overview:Zoomd Technologies Ltd. is a global marketing technology company that provides a user-acquisition and engagement platform, with a market cap of CA$118.94 million.
Operations:The company generates revenue of $68.93 million from its Internet Software & Services segment.
Market Cap:CA$118.94M
Zoomd Technologies Ltd., with a market cap of CA$118.94 million, presents a compelling case in the penny stock arena, driven by its robust financial health and strategic focus on growth. The company is debt-free and boasts a strong balance sheet with short-term assets of $29.9 million surpassing both short- and long-term liabilities significantly. Despite being dropped from the S&P/TSX Venture Composite Index recently, Zoomd's earnings have surged by 203.8% over the past year, showcasing high-quality earnings and an outstanding return on equity of 61.2%. The firm continues to explore M&A opportunities to enhance growth prospects further.
-
Dive into the specifics of Zoomd Technologies here with our thorough balance sheet health report.
-
Evaluate Zoomd Technologies' prospects by accessing our earnings growth report.
Summing It All Up
-
Explore the 370 names from our TSX Penny Stocks screener here.
-
Contemplating Other Strategies? The end of cancer? These 29 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include TSX:ECO TSX:TRX and TSXV:ZOMD.
This article was originally published by Simply Wall St .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
